Login to Your Account

Supreme Court reverses Federal Circuit in Promega patent spat

By Mark McCarty
Regulatory Editor

Friday, February 24, 2017

The Supreme Court of the U.S. has overturned a ruling by the Court of Appeals for the Federal Circuit in the case of Life Technologies v. Promega, but the outcome may do much more than declare that more than one component has to be involved in order to qualify as a “substantial component” of a purportedly infringing article.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription